Current challenges in acute bacterial skin infection management.
Journal
Current opinion in infectious diseases
ISSN: 1473-6527
Titre abrégé: Curr Opin Infect Dis
Pays: United States
ID NLM: 8809878
Informations de publication
Date de publication:
04 Jan 2024
04 Jan 2024
Historique:
medline:
5
1
2024
pubmed:
5
1
2024
entrez:
5
1
2024
Statut:
aheadofprint
Résumé
There are aspects of skin and soft tissue infections (SSTIs) that remain unresolved, such as current numbers, classification criteria, how best to define severity and predict the outcome, what diagnostic tests to perform, what new treatment options are available, or what the duration of antibiotic treatment should be. We have reviewed the literature over the last 18 months to clarify these issues and provide our opinion. SSTIs are common and among the top 10 most frequent infections worldwide. They represent a burden on the healthcare system and have a major impact on the quality of life of patients. Regarding classification, the Infectious Diseases Society of America (IDSA) provides a practical guide that distinguishes between uncomplicated and complicated infections, acute and chronic wound infections, and necrotising and nonnecrotizing infections based on skin extension and tissue necrosis. With new microbiological and imaging diagnostic techniques, SSTIs can now be better diagnosed. New PCR techniques are available, and mass spectrometry can be applied to samples collected in liquid transport media. Moreover, new treatment methods such as photodynamic therapy, reactive oxygen, and phages are emerging. SSTI patients can be treated with shorter antibiotic courses if they receive an active drug with good tissue penetration. Antibiotic treatment in necrotizing infections can be shortened to 48 h after the last debridement. SSTIs remain a challenge regarding rapid and accurate diagnosis and clinical management.
Identifiants
pubmed: 38179868
doi: 10.1097/QCO.0000000000000989
pii: 00001432-990000000-00130
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.
Références
Linder KE, Nicolau DP, Nailor MD. Epidemiology, treatment, and economics of patients presenting to the emergency department for skin and soft tissue infections. Hosp Pract 19952017; 45:9–15.
Sood A, Midha V, Goyal O, et al. Skin and soft tissue infections in cirrhotics: a prospective analysis of clinical presentation and factors affecting outcome. Indian J Gastroenterol 2014; 33:281–284.
Hemmersbach-Miller M, Catania J, Saullo JL. Updates on nocardia skin and soft tissue infections in solid organ transplantation. Curr Infect Dis Rep 2019; 21:27–35.
Ungaro R, Mikulska M. The skin and soft tissue infections in hematological patients. Curr Opin Infect Dis 2020; 33:101–109.
Shah S, Shelburne S. Skin and soft tissue infections in non-human immunodeficiency virus immunocompromised hosts. Infect Dis Clin North Am 2021; 35:199–217.
Senneville E, Albalawi Z, van Asten SA, et al. IWGDF/IDSA guidelines on the diagnosis and treatment of diabetes-related foot infections (IWGDF/IDSA 2023). Diabetes Metab Res Rev 2023; e3687–e3709. doi: 10.1002/dmrr.3687. [Online ahead of print].
doi: 10.1002/dmrr.3687.
Agency for Healthcare Research and Quality. HCUPnet: Healthcare Costs and Utilization Project. 2019. https://hcupnet.ahrq.gov/#query/ey [Accessed 21 October 2023].
Kaye KS, Petty LA, Shorr AF, Zilberberg MD. Current epidemiology, etiology, and burden of acute skin infections in the United States. Clin Infect Dis 2019; 68:S193–S199.
Raya-Cruz M, Ferullo I, Arrizabalaga-Asenjo M, et al. [Skin and soft-tissue infections in hospitalized patients: epidemiology, microbiological, clinical and prognostic factors]. Enferm Infecc Microbiol Clin 2014; 32:152–159.
Red Nacional de Vigilancia Epidemiológica. Survey on the prevalence of healthcare-associated infections (HCAIs) and antimicrobial usage in hospitals across Spain. 2019 EP-2018-2019 NACIONAL_web. [Accessed 21 October 2023].
EPINE. ESTUDIO EPINE-EPPS no. 32: 2022. 2022. 2022%20EPINE%20Informe%20Espa%C3%B1a%2020221201.pdf/reports-esp [Accessed 21 October 2023].
Morgan E, Hohmann S, Ridgway JP, et al. Decreasing incidence of skin and soft-tissue infections in 86 US Emergency Departments, 2009–2014. Clin Infect Dis 2019; 68:453–459.
Bookstaver PB, Jenkins TC, Stenehjem E, et al. Impact of outpatient vs inpatient ABSSSI treatment on Outcomes: a retrospective observational analysis of medical charts across US Emergency Departments. Open Forum Infect Dis 2018; 5:ofy109–ofy117.
Llopis F, González-Castillo J, Julián-Jiménez A, et al. [Review of 1.250 episodes of skin and soft tissue infections attended at 49 hospital emergency departments]. Rev Esp Quimioter 2014; 27:115–121.
Keyloun KR, Weber DJ, Gardstein BM, et al. Economic burden of hospital admissions for patients with acute bacterial skin and skin structure infections in the United States. Hosp Pract (1995) 2018; 46:278–286.
Global Burden of Disease Antimicrobial Resistance Collaborators Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 2022; 400:2221–2248.
Eron LJ, Lipsky BA, Low DE, et al. Managing skin and soft tissue infections: expert panel recommendations on key decision points. J Antimicrob Chemother 2003; 52: (Suppl 1): i3–i17.
Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis 2014; 59:e10–e52.
U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER). Guidance for industry: acute bacterial skin and skin structure infections: developing drugs for treatment. 2013. https://www.fda.gov/media/71052/download. [Accessed 21 October 2023].
Edelsberg J, Berger A, Weber DJ, et al. Clinical and economic consequences of failure of initial antibiotic therapy for hospitalized patients with complicated skin and skin-structure infections. Infect Control Hosp Epidemiol 2008; 29:160–169.
Bouza E, Burillo A. Current international and national guidelines for managing skin and soft tissue infections. Curr Opin Infect Dis 2022; 35:61–71.
Li S, Renick P, Senkowsky J, et al. Diagnostics for wound infections. Adv Wound Care (New Rochelle) 2021; 10:317–327.
Bouza E, Burillo A, Munoz P, et al. Semiquantitative culture of open surgical wounds for diagnosis of surgical site infection. Eur J Clin Microbiol Infect Dis 2004; 23:119–122.
Clay TB, Orwig KW, Stevens RA, et al. Correlation of MRSA polymerase chain reaction (PCR) wound swab testing and wound cultures in skin and soft tissue infections. Diagn Microbiol Infect Dis 2021; 100:115389–115392.
Matkoski C, Sharp SE, Kiska DL. Evaluation of the Q score and Q234 systems for cost-effective and clinically relevant interpretation of wound cultures. J Clin Microbiol 2006; 44:1869–1872.
Marchand-Senecal X, Brasg IA, Kozak R, et al. Impact of rejection of low-quality wound swabs on antimicrobial prescribing: a controlled before-after study. Open Forum Infect Dis 2021; 8:ofaa609–ofaa612.
Hitchcock AM, Seabury RW, Kufel WD, et al. Does a positive methicillin-resistant Staphylococcus aureus (MRSA) nasal screen predict the risk for MRSA skin and soft tissue infection? Ann Pharmacother 2023; 57:669–676.
Herrington M, Vuong NN, Feng C, Hwang H. Evaluation of methicillin-resistant Staphylococcus aureus (MRSA) nasal swab screening in patients with cancer at a large comprehensive cancer center. In: I.D.S.A., editor. ID Week October 14, 2023; Boston, MA; 2023. Poster 2217.
Miller JM, Binnicker MJ, Campbell S, et al. A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2018 update by the Infectious Diseases Society of America and the American Society for Microbiology. Clin Infect Dis 2018; 67:e1–e94.
Bridwell MR, Bajaj S, Gress TW, et al. Impact of MRSA polymerase chain reaction (PCR) wound swabs on antibiotic de-escalation in skin and soft tissue infections. Diagn Microbiol Infect Dis 2022; 103:115722–115726.
Petts DN, Lane A, Kennedy P, et al. Direct detection of groups A, C and G streptococci in clinical specimens by a trivalent colour test. Eur J Clin Microbiol Infect Dis 1988; 7:34–39.
Tsuge I, Matsui M, Nakamura T, et al. Group A streptococcal rapid antigen detection test: a clinical study to evaluate the reproducibility using human wound samples. Eplasty 2022; 22:e53–57.
Close RM, Sutcliffe CG, Galdun P, et al. Point-of-care molecular diagnostics for the detection of group A Streptococcus in noninvasive skin and soft tissue infections: a validation study. Diagn Microbiol Infect Dis 2022; 103:115729–115734.
Lee PC, Turnidge J, McDonald PJ. Fine-needle aspiration biopsy in diagnosis of soft tissue infections. J Clin Microbiol 1985; 22:80–83.
Newell PM, Norden CW. Value of needle aspiration in bacteriologic diagnosis of cellulitis in adults. J Clin Microbiol 1988; 26:401–404.
Kulthanan K, Rongrungruang Y, Siriporn A, et al. Clinical and microbiologic findings in cellulitis in Thai patients. J Med Assoc Thai 1999; 82:587–592.
Patel Wylie F, Kaplan SL, Mason EO, Allen CH. Needle aspiration for the etiologic diagnosis of children with cellulitis in the era of community-acquired methicillin-resistant Staphylococcus aureus. Clin Pediatr (Phila) 2011; 50:503–507.
Johnson KE, Kiyatkin DE, An AT, et al. PCR offers no advantage over culture for microbiologic diagnosis in cellulitis. Infection 2012; 40:537–541.
Collazos J, de la Fuente B, Garcia A, et al. Cellulitis in adult patients: a large, multicenter, observational, prospective study of 606 episodes and analysis of the factors related to the response to treatment. PLoS One 2018; 13:e0204036–e204050.
Duvanel T, Auckenthaler R, Rohner P, et al. Quantitative cultures of biopsy specimens from cutaneous cellulitis. Arch Intern Med 1989; 149:293–296.
Esposito S, De Simone G, Gioia R, et al. Deep tissue biopsy vs. superficial swab culture, including microbial loading determination, in the microbiological assessment of skin and soft tissue infections (SSTIs). J Chemother 2017; 29:154–158.
Bouza E, Onori R, Semiglia-Chong MA, et al. Fast track SSTI management program based on a rapid molecular test (GeneXpert(R) MRSA/SA SSTI) and antimicrobial stewardship. J Microbiol Immunol Infect 2020; 53:328–335.
Esposito S, Bassetti M, Bonnet E, et al. Hot topics in the diagnosis and management of skin and soft-tissue infections. Int J Antimicrob Agents 2016; 48:19–26.
van Daalen FV, Kallen MC, van den Bosch CMA, et al. Clinical condition and comorbidity as determinants for blood culture positivity in patients with skin and soft-tissue infections. Eur J Clin Microbiol Infect Dis 2017; 36:1853–1858.
Madsen MB, Skrede S, Perner A, et al. Patient's characteristics and outcomes in necrotising soft-tissue infections: results from a Scandinavian, multicentre, prospective cohort study. Intensive Care Med 2019; 45:1241–1251.
Barbic D, Chenkin J, Cho DD, et al. In patients presenting to the emergency department with skin and soft tissue infections what is the diagnostic accuracy of point-of-care ultrasonography for the diagnosis of abscess compared to the current standard of care? A systematic review and meta-analysis. BMJ Open 2017; 7:e013688–e13695.
Gottlieb M, Avila J, Chottiner M, Peksa GD. Point-of-care ultrasonography for the diagnosis of skin and soft tissue abscesses: a systematic review and meta-analysis. Ann Emerg Med 2020; 76:67–77.
Wu J, Ge L, Wang X, Jin Y. Role of point-of-care ultrasound (POCUS) in the diagnosis of an abscess in paediatric skin and soft tissue infections: a systematic review and meta-analysis. Med Ultrason 2022; 24:339–347.
Rahmani E, Fayyazishishavan E, Afzalian A, et al. Point-of-care ultrasonography for identification of skin and soft tissue abscess in adult and pediatric patients; a systematic review and meta-analysis. Arch Acad Emerg Med 2023; 11:e49–e61.
Sartelli M, Guirao X, Hardcastle TC, et al. 2018 WSES/SIS-E consensus conference: recommendations for the management of skin and soft-tissue infections. World J Emerg Surg 2018; 13:58–80.
Ray-Zack MD, Hernandez MC, Younis M, et al. Validation of the American Association for the Surgery of Trauma emergency general surgery grade for skin and soft tissue infection. J Trauma Acute Care Surg 2018; 84:939–945.
Narang R, Mohammadi S, Ashani MM, et al. Sensitive, real-time and non-intrusive detection of concentration and growth of pathogenic bacteria using microfluidic-microwave ring resonator biosensor. Sci Rep 2018; 8:15807–15816.
Marwick C, Broomhall J, McCowan C, et al. Severity assessment of skin and soft tissue infections: cohort study of management and outcomes for hospitalized patients. J Antimicrob Chemother 2011; 66:387–397.
Cutfield T, Walter H, Hobbs M, et al. Association of the Dundee severity classification with mortality, length of stay and readmission in adult inpatients with cellulitis. J Antimicrob Chemother 2019; 74:200–206.
Rath E, Skrede S, Oppegaard O, Bruun T. Nonpurulent skin and soft tissue infections: predictive power of a severity score and the appropriateness of treatment in a prospective cohort. Infect Dis (Lond) 2020; 52:361–371.
Ritchie SR, Cutfield T, Lee A, et al. The impact of the Auckland cellulitis pathway on length of hospital stay, mortality readmission rate, and antibiotic stewardship. Clin Infect Dis 2021; 73:859–865.
Ruiz C, Gibson G, Crosby J, et al. Assessing empiric antimicrobial therapy with the Modified Dundee classification for nonpurulent skin and soft tissue infections in a community hospital system. Open Forum Infect Dis 2023; 10:ofad186–ofad191.
Marwick C, Rae N, Irvine N, Davey P. Prospective study of severity assessment and management of acute medical admissions with skin and soft tissue infection. J Antimicrob Chemother 2012; 67:1016–1019.
Raff AB, Weng QY, Cohen JM, et al. A predictive model for diagnosis of lower extremity cellulitis: a cross-sectional study. J Am Acad Dermatol 2017; 76:618–625.e2.
Walker TD, Gilkey TW, Trinidad JC, et al. Evaluation of Dundee and ALT-70 predictive models for cellulitis in 56 patients who underwent tissue culture. Arch Dermatol Res 2023; 315:665–668.
Wong CH, Khin LW, Heng KS, et al. The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections. Crit Care Med 2004; 32:1535–1541.
Savage SA, Li SW, Utter GH, et al. The EGS grading scale for skin and soft-tissue infections is predictive of poor outcomes: a multicenter validation study. J Trauma Acute Care Surg 2019; 86:601–608.
Lipsky BA, Kollef MH, Miller LG, et al. Predicting bacteremia among patients hospitalized for skin and skin-structure infections: derivation and validation of a risk score. Infect Control Hosp Epidemiol 2010; 31:828–837.
Ko LN, Garza-Mayers AC, St John J, et al. Effect of dermatology consultation on outcomes for patients with presumed cellulitis: a randomized clinical trial. JAMA Dermatol 2018; 154:529–536.
Pulido-Perez A, Bergon-Sendin M, Suarez-Fernandez R, et al. Skin and sepsis: contribution of dermatology to a rapid diagnosis. Infection 2021; 49:617–629.
Gelbard RB, Ferrada P, Yeh DD, et al. Optimal timing of initial debridement for necrotizing soft tissue infection: a Practice Management Guideline from the Eastern Association for the Surgery of Trauma. J Trauma Acute Care Surg 2018; 85:208–214.
Nawijn F, van Heijl M, Keizer J, et al. The impact of operative time on the outcomes of necrotizing soft tissue infections: a multicenter cohort study. BMC Surg 2022; 22:3.
Kobayashi L, Konstantinidis A, Shackelford S, et al. Necrotizing soft tissue infections: delayed surgical treatment is associated with increased number of surgical debridements and morbidity. J Trauma 2011; 71:1400–1405.
Yamaga S, Shime N. The role of source control in septic patients. Crit Care Med 2017; 45:e618–e619.
Martinez ML, Ferrer R, Torrents E, et al. Impact of source control in patients with severe sepsis and septic shock. Crit Care Med 2017; 45:11–19.
Stieferman AE, Mazi P, Burnham JP. Severe skin and soft-tissue infections. Semin Respir Crit Care Med 2022; 43:3–9.
Latifi R, Patel AS, Samson DJ, et al. The roles of early surgery and comorbid conditions on outcomes of severe necrotizing soft-tissue infections. Eur J Trauma Emerg Surg 2019; 45:919–926.
Chen IW, Yang HM, Chiu CH, et al. Clinical characteristics and risk factor analysis for lower-extremity amputations in diabetic patients with foot ulcer complicated by necrotizing fasciitis. Medicine (Baltimore) 2015; 94:e1957–e1963.
Abu El Hawa AA, Dekker PK, Mishu MD, et al. Early diagnosis and surgical management of necrotizing fasciitis of the lower extremities: risk factors for mortality and amputation. Adv Wound Care (New Rochelle) 2022; 11:217–225.
Pham TN, Moore ML, Costa BA, et al. Assessment of functional limitation after necrotizing soft tissue infection. J Burn Care Res 2009; 30:301–306.
Traineau H, Charpentier C, Lepeule R, et al. First-year recurrence rate of skin and soft tissue infections following an initial necrotizing soft tissue infection of the lower extremities: a retrospective cohort study of 93 patients. J Am Acad Dermatol 2023; 88:1360–1363.
Müllner T, Mrkonjic L, Kwasny O, Vécsei V. The use of negative pressure to promote the healing of tissue defects: a clinical trial using the vacuum sealing technique. Br J Plast Surg 1997; 50:194–199.
Mouës CM, Vos MC, van den Bemd GJ, et al. Bacterial load in relation to vacuum-assisted closure wound therapy: a prospective randomized trial. Wound Repair Regen 2004; 12:11–17.
Duan H, He Y, Zhang H, et al. Vacuum sealing drainage with instillation in the treatment of necrotising soft-tissue infection: a retrospective analysis. J Wound Care 2020; 29:510–517.
Hong KS, Yi HJ, Lee RA, et al. Prognostic factors and treatment outcomes for patients with Fournier's gangrene: a retrospective study. Int Wound J 2017; 14:1352–1358.
Isaac AL, Armstrong DG. Negative pressure wound therapy and other new therapies for diabetic foot ulceration: the current state of play. Med Clin North Am 2013; 97:899–909.
Andros G, Armstrong DG, Attinger CE, et al. Consensus statement on negative pressure wound therapy (V.A.C. Therapy) for the management of diabetic foot wounds. Ostomy Wound Manage 2006; (Suppl): 1–32.
Armstrong DG, Lavery LA. Diabetic Foot Study C Negative pressure wound therapy after partial diabetic foot amputation: a multicentre, randomised controlled trial. Lancet 2005; 366:1704–1710.
Cieplik F, Deng D, Crielaard W, et al. Antimicrobial photodynamic therapy - what we know and what we don’t. Crit Rev Microbiol 2018; 44:571–589.
Perez-Laguna V, Garcia-Luque I, Ballesta S, et al. Photodynamic therapy combined with antibiotics or antifungals against microorganisms that cause skin and soft tissue infections: a planktonic and biofilm approach to overcome resistances. Pharmaceuticals (Basel) 2021; 14:1–21.
Asilian A, Davami M. Comparison between the efficacy of photodynamic therapy and topical paromomycin in the treatment of Old World cutaneous leishmaniasis: a placebo-controlled, randomized clinical trial. Clin Exp Dermatol 2006; 31:634–637.
Wang X, Wang X, Lei X, et al. Photodynamic therapy: a new approach to the treatment of Nontuberculous Mycobacterial skin and soft tissue infections. Photodiagnosis Photodyn Ther 2023; 43:103645–103651.
Lei X, Liu B, Huang Z, Wu J. A clinical study of photodynamic therapy for chronic skin ulcers in lower limbs infected with Pseudomonas aeruginosa. Arch Dermatol Res 2015; 307:49–55.
Dryden M. Novel techniques in the treatment of skin and soft tissue infection. Curr Opin Infect Dis 2022; 35:72–78.
Metsemakers WJ, Onsea J, Moriarty TF, et al. Bacteriophage therapy for human musculoskeletal and skin/soft tissue infections. Clin Microbiol Infect 2023; 29:695–701.
Kutateladze M, Adamia R. Phage therapy experience at the Eliava Institute. Med Mal Infect 2008; 38:426–430.
Valadez MG, Patel N, Chong V, et al. Short courses of antibiotics are safe in necrotizing soft tissue infections. Am Surg 2021; 87:1666–1671.
Kenneally AM, Warriner Z, VanHoose JD, et al. Evaluation of antibiotic duration after surgical debridement of necrotizing soft tissue infection. Surg Infect (Larchmt) 2022; 23:357–363.
Lee RA, Stripling JT, Spellberg B, Centor RM. Short-course antibiotics for common infections: what do we know and where do we go from here? Clin Microbiol Infect 2023; 29:150–159.
Hepburn MJ, Dooley DP, Skidmore PJ, et al. Comparison of short-course (5 days) and standard (10 days) treatment for uncomplicated cellulitis. Arch Intern Med 2004; 164:1669–1674.
Prokocimer P, De Anda C, Fang E, et al. Tedizolid phosphate vs linezolid for treatment of acute bacterial skin and skin structure infections: the ESTABLISH-1 randomized trial. JAMA 2013; 309:559–569.
Moran GJ, Fang E, Corey GR, et al. Tedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin-structure infections (ESTABLISH-2): a randomised, double-blind, phase 3, noninferiority trial. Lancet Infect Dis 2014; 14:696–705.
Cranendonk DR, Opmeer BC, van Agtmael MA, et al. Antibiotic treatment for 6 days versus 12 days in patients with severe cellulitis: a multicentre randomized, double-blind, placebo-controlled, noninferiority trial. Clin Microbiol Infect 2020; 26:606–612.
Pham TT, Gariani K, Richard JC, et al. Moderate to severe soft tissue diabetic foot infections: a randomized, controlled, pilot trial of postdebridement antibiotic treatment for 10 versus 20 days. Ann Surg 2022; 276:233–238.
Terzian WTH, Nunn AM, Call EB, et al. Duration of antibiotic therapy in necrotizing soft tissue infections: shorter is safe. Surg Infect (Larchmt) 2022; 23:430–435.